Back
Krystal Biotech Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
59
KRYS
Krystal Biotech
Last Price:
197.12
Seasonality Move:
26.4%
Sell
30
ALNY
Alnylam Pharmaceuticals
Last Price:
255.18
Seasonality Move:
7.55%
Buy
59
Krystal Biotech (KRYS)
is a Buy
Is Krystal Biotech a Buy, Sell or Hold?
- The current Krystal Biotech [KRYS] share price is $196.52. The Score for KRYS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- KRYS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $253.35. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KRYS Stock Price Chart
What is Krystal Biotech's stock price today?
-
The Krystal Biotech share price today is $196.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRYS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $253.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
KRYS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.69 | Buy |
| Relative Strength Index (14 RSI): | 62.93 | Buy |
| Chaikin Money Flow: | 156170 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (172.59 - 189.37) | Buy |
| Bollinger Bands (100): | (176.6 - 199.34) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.33 | Sell |
| Relative Strength Index (14 RSI): | 44.29 | Sell |
| Chaikin Money Flow: | 851531 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (247.71 - 283.73) | Sell |
| Bollinger Bands (100): | (248.8 - 281.72) | Sell |
KRYS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 183.26 | Buy |
| 20-day SMA: | 182.42 | Buy |
| 50-day SMA: | 179.94 | Buy |
| 200-day SMA: | 175.91 | Buy |
| 8-day EMA: | 187.49 | Buy |
| 20-day EMA: | 183.6 | Buy |
| 50-day EMA: | 182.54 | Buy |
| 200-day EMA: | 171.19 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 243.36 | Buy |
| 20-day SMA: | 259.9 | Sell |
| 50-day SMA: | 271.86 | Sell |
| 200-day SMA: | 212.45 | Buy |
| 8-day EMA: | 249.92 | Buy |
| 20-day EMA: | 258.06 | Sell |
| 50-day EMA: | 264.29 | Sell |
| 200-day EMA: | 231.45 | Buy |
Krystal Biotech Earnings Growth & KRYS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.65 per share, and an increase next year of $1.53 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.
Krystal Biotech Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||